UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

When the MET receptor kicks in to resist targeted therapies

Oncogene, 2021-06, Vol.40 (24), p.4061-4078

2021

Volltextzugriff (PDF)

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.741-751

2020

Volltextzugriff (PDF)

The multiple paths towards MET receptor addiction in cancer

Oncogene, 2018-06, Vol.37 (24), p.3200-3215

2018

Volltextzugriff (PDF)

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211015493

2021

Volltextzugriff (PDF)

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1873-1883

2018

Volltextzugriff (PDF)

Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.366-369

2020

Volltextzugriff (PDF)

Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case report

European thyroid journal, 2022-08, Vol.11 (4), p.1-6

2022

Volltextzugriff (PDF)

Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice

Clinical lung cancer, 2019-07, Vol.20 (4), p.297-304.e1

2019

Volltextzugriff (PDF)

Relevance of detection of RAF fusion in pan-negative melanoma in routine practice

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21500-e21500

2022

Volltextzugriff (PDF)

Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice

Melanoma research, 2024-04, Vol.34 (2), p.182-185

2024

Volltextzugriff (PDF)

Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene

Melanoma research, 2023-06, Vol.33 (3), p.247-251

2023

Volltextzugriff (PDF)

Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma

The oncologist (Dayton, Ohio), 2023-01, Vol.28 (1), p.80-83

2023

Volltextzugriff (PDF)

Prise en charge néo-adjuvante par pembrolizumab d’un carcinome épidermoïde de la paupière

Annales de Dermatologie et de Vénéréologie - FMC, 2021-12, Vol.1 (8), p.A182

2021

Volltextzugriff (PDF)

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.120-124

2020

Volltextzugriff (PDF)

Abstract 3683: MET exon 14 skipping mutations in lung cancer: Screening, functional and clinical impact

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3683-3683

2020

Volltextzugriff (PDF)

Ipilimumab combined with stereotactic radiosurgery in melanoma patients with brain metastases: A multicenter, open label, phase 2 trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9520-9520

2018

Volltextzugriff (PDF)

Abstract P5-02-13: Triple negative breast cancer, the impact of isotype-specific progesterone receptor antibodies on the diagnosis results

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-02-13

2015

Volltextzugriff (PDF)

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.120-124

2020

Volltextzugriff (PDF)

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

Targeted oncology, 2023-07, Vol.18 (4), p.585-591

2023

Volltextzugriff (PDF)

Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases

Melanoma research, 2016-04, Vol.26 (2), p.153-156

2016

Volltextzugriff (PDF)

Réponse clinique et radiologique de mélanomes BRAF p.Thr599dup mutés, sous inhibiteurs de la voie MAP kinase

Annales de Dermatologie et de Vénéréologie - FMC, 2021-12, Vol.1 (8), p.A72-A73

2021

Volltextzugriff (PDF)

Clinical and pathologic correlation of the activated form of the androgen receptor (AR) in breast cancer (BC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.590-590

2014

Volltextzugriff (PDF)

MA 07.06 Detection of Mechanisms of Resistance to ALK Inhibitors in Routine Practice: A Retrospective Study

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1828-S1828

2017

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(31)
Life Sciences
(23)
Humans
(20)
Oncology
(18)
Female
(10)
Male
(9)
Middle Aged
(9)
Mutation
(8)
Adult
(6)
Aged
(6)
Cancer
(6)
Human Health And Pathology
(6)
Patients
(6)
Prognosis
(6)
Treatment Outcome
(6)
Lung Cancer
(5)
Lung Neoplasms - Genetics
(5)
Retrospective Studies
(5)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

When the MET receptor kicks in to resist targeted therapies

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

The multiple paths towards MET receptor addiction in cancer

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma

MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice

Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case report

Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice

Relevance of detection of RAF fusion in pan-negative melanoma in routine practice

Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice

Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene

Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma

Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial

Prise en charge néo-adjuvante par pembrolizumab d’un carcinome épidermoïde de la paupière

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

Abstract 3683: MET exon 14 skipping mutations in lung cancer: Screening, functional and clinical impact

Ipilimumab combined with stereotactic radiosurgery in melanoma patients with brain metastases: A multicenter, open label, phase 2 trial

Abstract P5-02-13: Triple negative breast cancer, the impact of isotype-specific progesterone receptor antibodies on the diagnosis results

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases

Réponse clinique et radiologique de mélanomes BRAF p.Thr599dup mutés, sous inhibiteurs de la voie MAP kinase

Clinical and pathologic correlation of the activated form of the androgen receptor (AR) in breast cancer (BC)

MA 07.06 Detection of Mechanisms of Resistance to ALK Inhibitors in Routine Practice: A Retrospective Study

Suchergebnisse filtern